203 related articles for article (PubMed ID: 2144368)
1. [Hormonal control of disseminated breast cancer].
Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu
Sov Med; 1990; (6):94-7. PubMed ID: 2144368
[No Abstract] [Full Text] [Related]
2. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
Dryzhak VI
Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239
[No Abstract] [Full Text] [Related]
3. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen therapy of metastatic breast cancer.
Manni A
J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
[TBL] [Abstract][Full Text] [Related]
5. [Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
Onkologie; 1982 Aug; 5 Suppl():34-41. PubMed ID: 6290955
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant hormone therapy of primary breast cancer. Review of the literature].
Focan C
Rev Med Liege; 1991 May; 46(5):270-8. PubMed ID: 1830160
[No Abstract] [Full Text] [Related]
7. [Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Wander HE; Nagel GA; Blossey HC
Onkologie; 1982 Aug; 5 Suppl():28-33. PubMed ID: 6215600
[TBL] [Abstract][Full Text] [Related]
8. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
Petru E; Schmähl D
Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
[TBL] [Abstract][Full Text] [Related]
9. [Medical treatment of the breast].
Battelli T; Manocchi P; Guistini L; Mattioli R; Ginnetti A
Minerva Med; 1984 Feb; 75(6):227-33. PubMed ID: 6231491
[No Abstract] [Full Text] [Related]
10. [Endocrine therapy of breast cancer].
Jonat W; Maass H
Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805
[TBL] [Abstract][Full Text] [Related]
11. [Current status of drug treatment of endometrial carcinoma].
Schulz KD; Kaiser R
Gynakologe; 1983 Jun; 16(2):114-8. PubMed ID: 6193040
[No Abstract] [Full Text] [Related]
12. [Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
Wander HE; Kleeberg UR; Essers U; Blossey HC; Nagel GA
Onkologie; 1987 Oct; 10(5):321-3. PubMed ID: 2960938
[No Abstract] [Full Text] [Related]
13. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
[TBL] [Abstract][Full Text] [Related]
14. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
Van Deijk WA; Blijham GH; Mellink WA; Meulenberg PM
Cancer Treat Rep; 1985 Jan; 69(1):85-90. PubMed ID: 3155651
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
[No Abstract] [Full Text] [Related]
16. [A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
Tsumura I; Okamura Y; Takatsuka Y; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1509-12. PubMed ID: 2143889
[TBL] [Abstract][Full Text] [Related]
17. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
Konstantinova MM; Gershanovich MA
Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
[TBL] [Abstract][Full Text] [Related]
18. Hormonal treatment of disseminated male breast cancer.
Lopez M; Di Lauro L; Lazzaro B; Papaldo P
Oncology; 1985; 42(6):345-9. PubMed ID: 2933617
[TBL] [Abstract][Full Text] [Related]
19. [Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].
Possinger K; Wagner H; Langecker P; Schmid L; Willich S; Wilmanns W
Fortschr Med; 1987 Jul; 105(22):421-4. PubMed ID: 2958397
[No Abstract] [Full Text] [Related]
20. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
Nomura Y; Tashiro H; Hisamatsu K; Toi M
Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]